GRDN Stock Analysis: Buy, Sell, or Hold?
GRDN - Guardian Pharmacy Services, Inc.
$42.00
-0.13 (-0.31%)
▼
5d:
+8.02%
30d:
+7.91%
90d:
+11.64%
BUY
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When GRDN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: GRDN shows positive signals but monitor for confirmation. Market pricing in 3.1% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: GRDN shows positive signals but monitor for confirmation. Market pricing in 3.1% annual growth which appears achievable. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$45.21
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$28.07
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GRDN is currently trading at $42.00, which is considered slightly high relative to its 30-day fair value range of $39.17 to $42.49. The stock's valuation (Forward PE: 30.9) is in line with its historical norms (28.2). At these levels, the market is pricing in 3.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GRDN is in a strong uptrend. The price is approaching resistance at $42.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $47.00 (+11.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, GRDN is in a strong uptrend. The price is approaching resistance at $42.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $47.00 (+11.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$39.17 -
$42.49
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
70.8%
All Signals
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($47.00)
- NEUTRAL: Market pricing in 3.1% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$39.17 -
$42.49
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$2.66
(6.3%)
Support & Resistance Levels
Support Level
$37.33
Resistance Level
$42.00
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
30.92
Wall Street Target
$47.00
(+11.9%)
Revenue Growth (YoY)
2.2%
Earnings Growth (YoY)
39.0%
Profit Margin
3.6%
Valuation Premium vs History
+3.1% premium
PE vs Historical
30.9 vs 28.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.1%
(market-implied from PE analysis)
1-Year Target
$43.30
(+3%)
2-Year Target
$44.64
(+6%)
3-Year Target
$46.03
(+10%)
3-Yr Target (if PE normalizes)
(PE: 31→28)
PE COMPRESSION
$41.98
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 30.9, Growth: 7.8%)
$52.62
(+25%)
Base:
(SPY PE: 21.8, Growth: 7.8%)
$37.06
(-12%)
Bear:
(PE: 18.5, Growth: 7.8%)
$31.50
(-25%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (34x PE), but valuation improves significantly next year (31x PE) as earnings recover.
Forward PE: 34.25 | Forward EPS (Implied): $1.23
Bull Case
$50.72
(+21%)
Analyst growth 15.0%, PE expands to 36.0
Base Case
$42.00
(0%)
Market implied 0.0%, PE stable at 34.3
Bear Case
$32.13
(-24%)
Severe decline -15.0%, PE contracts to 30.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 03, 2026 11:32 PM ET
Data refreshes hourly during market hours. Next update: 12:32 AM
Data refreshes hourly during market hours. Next update: 12:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GRDN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Equity Fund L.P. Cardinal
SELL
275728 shares
2026-03-20
Fred Burke
SELL
671432 shares
2026-03-20
John Ackerman
SELL
1103364 shares
2026-03-20
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$243 | 57 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$500 | 66 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 53 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 60 BUY |
Advanced GRDN Option Strategies
Professional options setups generated by AI based on today's GRDN price and gamma walls.
